2种组胺受体拮抗剂对低温诱发的肉鸡肺动脉高压的影响

为探讨组胺H1受体拮抗剂扑尔敏和H2受体拮抗剂西咪替丁对低温诱发的肉鸡肺动脉高压的影响,并由此推测组胺在低温诱发的肉鸡肺动脉高压形成过程中的作用。140只17日龄AA肉鸡随机分为4组。(1)常温组:40只在常温条件下饲养(22～23℃),每日注射生理盐水2次;(2)低温组:40只在低温环境中饲养(9～11℃),每日注射生理盐水2次;(3)扑尔敏组:40只在低温环境中饲养(9～11℃),每日注射扑尔敏2次;(4)西咪替丁组:20只在低温环境中饲养(9～11℃),于24日龄至38日龄期间每日注射西咪替丁2次。分别于低温处理后1周(24日龄)、2周(31日龄)、3周(38日龄)、4周(45日龄)从常温组,低温组,扑尔敏组中各随机抽取10只,西咪替丁组在低温处理后2周(31日龄)、3周(38日龄)各随机抽取10只,称取体重,然后利用右心导管法测定肺动脉压(PAP),并测定红细胞压积(PCV),腹水心脏指数(AHI)。结果发现:(1)24日龄、31日龄、38日龄时,低温组肺动脉收缩压,舒张压显著高于(P<0105)或极显著高于(P<0101)同日龄常温组。24日龄时扑尔敏组肺动脉收缩压显著低于(P<0105)同日龄低温组。38日龄时西咪替丁组肺动脉收缩压,舒张压极显著低于(P<0101)同日龄低温组。(2)24日龄、31日龄、38日龄、45日龄时,低温组PCV极显著高于(P<0101)同日龄常温组。24日龄时扑尔敏组     

Immobilization of African buffaloes (Syncerus caffer) using etorphine–midazolam compared with etorphine–azaperone

ObjectiveTo compare induction times and physiological effects of etorphine–azaperone with etorphine–midazolam immobilization in African buffaloes.Study designRandomized crossover study.AnimalsA group of 10 adult buffalo bulls (mean body weight 353 kg).MethodsEtorphine–azaperone (treatment EA; 0.015 and 0.15 mg kg^–1, respectively) and etorphine–midazolam (treatment EM; 0.015 and 0.15 mg kg^–1, respectively) were administered once to buffaloes, 1 week apart. Once in sternal recumbency, buffaloes were instrumented and physiological variables recorded at 5 minute intervals, from 5 minutes to 20 minutes. Naltrexone (20 mg mg^–1 etorphine dose) was administered intravenously at 40 minutes. Induction (dart placement to recumbency) and recovery (naltrexone administration to standing) times were recorded. Arterial blood samples were analysed at 5 and 20 minutes. Physiological data were compared between treatments using a general linear mixed model and reported as mean ± standard deviation. Time data were compared using Mann-Whitney U test and reported as median (interquartile range) with p ≤ 0.05.ResultsActual drug doses administered for etorphine, azaperone and midazolam were 0.015 ± 0.001, 0.15 ± 0.01 and 0.16 ± 0.02 mg kg^–1, respectively. Induction time for treatment EA was 3.3 (3.6) minutes and not different from 3.2 (3.2) minutes for treatment EM. The overall mean arterial blood pressure was significantly lower for treatment EA (102 ± 25 mmHg) than that for treatment EM (163 ± 18 mmHg) (p < 0.001). The PaO₂ for treatment EA (37 ± 12 mmHg; 5.0 ± 1.6 kPa) was not different from that for treatment EM (43 ± 8 mmHg; 5.8 ± 1.1 kPa). Recovery time was 0.8 (0.6) minutes for treatment EA and did not differ from 1.1 (0.6) minutes for treatment EM.Conclusions and clinical relevanceTreatment EA was as effective as treatment EM for immobilization in this study. However, systemic arterial hypertension was a concern with treatment EM, and both combinations produced clinically relevant hypoxaemia. Supplemental oxygen administration is recommended with both drug combinations.     

The suitability of some blood gas and biochemical parameters as diagnostic tools or early indicators of ascites syndrome in broiler sire lines

In recent few years, there have been some attempts to find a reliable indicator trait as a selection criterion against susceptibility to ascites syndrome (AS). Blood parameters were of great interest as they could be measured in live animals without implementing an ascites‐inducing challenge (AIC). In this work, the suitability of some blood parameters was evaluated for diagnosing AS‐susceptible chicks in later steps of the disease in trial 1 as well as their early predictive ability in trial 2. In the first trial, one hundred 1‐day‐old chicks from two pure broiler lines namely S₁ and S₂ and, in the second trial, 226 1‐day‐old chicks from line S₂ were subjected to AIC. Saline drinking water (1200 mg/l) and lower‐than‐standard ambient temperatures were the implemented AICs in trials 1 and 2 respectively. The blood parameters including pH, partial pressure of O₂ (pO₂), partial pressure of CO₂ (pCO₂), bicarbonate ion concentration (BIC), percentage of haematocrit (HCT) and saturated haemoglobin (SaO₂) were measured twice per each bird at days 28 and 35 in trial 1 and once in trial 2 at day 21. The results of the first trial revealed that in line S₂ some of the blood parameters differed significantly between the ascitic and non‐ascitic groups following exposure to AIC. In this line, the incidence of AS was accompanied by a lower pO₂, SaO₂ and BIC, while with higher pCO₂ and HCT values. In the second trial, however, although almost all of the parameters showed meaningful differences between the ascitic and non‐ascitic broilers, only mean difference of BIC parameter was statistically significant. The general conclusion of this study is that the blood parameters can somewhat have diagnostic ability in the condition in which the AIC is already present, whereas the results did not approve their usefulness as early predictors of AS.     

饮水高钠致肉鸡急性和慢性肺动脉高压综合征

为了探讨肉鸡肺动脉高压综合征 (PHS)的发病机制 ,将 2 4 0羽 1日龄健康AA肉鸡随机均分为对照组 (C)、试验Ⅰ组 (T1)和试验Ⅱ组 (T2 )。从 8日龄起实验组在饮水中添加Na+ ,使水中Na+ 含量分别达 6 0 0和 12 0 0mg·L-1,动态观察和检测各组肉鸡临床表现、PHS发病率、右心与全心重量比 (RV/TV)、红细胞压积 (PCV)、红细胞滤过指数 (FI)和血容量 (BV) ,对各组患病鸡与对照鸡的肺小动脉结构变化进行动态检测和比较分析。结果显示 ,饮水高钠成功诱发了肉鸡PHS ,并显著提高了肉鸡PHS发病率、RV/TV和PCV (P <0 0 5 )。在 2 8日龄以前 ,试验组患病鸡的FI和BV显著增加 (P <0 0 5 ) ,而血管肌化百分率 (%MA和 %WTPV)、管壁面积与管总面积之比 (WA/TA)、平均中膜厚度 (mMTPA)和血管非肌化百分率 (%NMA)无显著差异。 35和 4 2日龄时 ,试验组患病鸡肺血管 %MA、%WTPV、WA/TA和mMTPA显著增加 (P <0 0 5 ) ,%NMA则显著降低 (P <0 0 5 ) ,但FI和BV无变化。从而揭示了饮水高钠使 14～ 2 1日龄的PHS患鸡出现了以肺动脉血流量增加和肺血管阻力升高的血液流变力学变化为主要特征的急性肺动脉高压综合征。使 35～ 4 2日龄的PHS患鸡出现了以肺小动脉肌型化和管壁增生肥厚的血管重构为主要特征的慢性肺动脉高压综合征。     

Effects of monocrotaline-induced pulmonary hypertension on expression of Hippo signaling pathway-related molecules in rat lung

AIM:To investigate the expression of Hippo signaling pathway-related molecules in the lung tissues of the rats with pulmonary hypertension induced by monocrotaline for exploring the significance of Hippo signaling pathway in the development of pulmonary hypertension. METHODS:SD rats (n=45) were randomly divided into control group (n=15) and model group (n=30). The rats in model group was given neck subcutaneous injection of monocrota-line at 60 mg/kg to establish pulmonary hypertension model, and the rats in control group was injected with the same volume of normal saline. Four weeks later, right ventricular systolic pressure (RVSP) was measured by right cardiac catheterization, and right ventricular hypertrophy index (RVHI) and right ventricular mass index (RVMI) were calculated. The remodeling of the pulmonary arterioles was observed by HE staining, and medial thickness/external diameter (M/E%) was evaluated. The fibrosis of lung tissues was detected by Masson staining. The protein expression of Yes-associated protein (YAP), tafazzin (TAZ) and TEAD was detected by immunohistochemistry, and the protein and mRNA levels of YAP, TAZ and TEAD in lung tissues were determined by Western blot and RT-qPCR. RESULTS:Compared with control group, the vascular wall in model group was thickened significantly, the M/E% was increased (P<0.01), the pulmonary fibrosis was obvious, and the RVSP and RVHI in model group were significantly higher than those in control group (P<0.01). The immunohistochemical staining showed that the protein expression of YAP, TAZ and TEAD in the pulmonary arterioles in model group was significantly higher than that in control group. The YAP, TAZ and TEAD protein and mRNA levels in the lung tissues were also higher than those in control group (P<0.05). CONCLUSION:The activation of Hippo signaling molecules may promote the remodeling of pulmonary arterioles and further regulate the development of monocrotaline-induced pulmonary hypertension.     

Effect of hypercapnia on lysyl oxidase-dependent collagen cross-linking and hypoxia-induced pulmonary hypertension in rat

AIM: To investigate the effect of hypercapnia on hypoxia-induced pulmonary hypertension and the changes of lysyl oxidase (LOX) and extracellular matrix collagen cross-links in the rat. METHODS: Sprague-Dawley rats were randomly divided into 4 groups:normoxia group, hypoxia group, hypercapnia group and hypoxia+hypercapnia group. LOX activity was detected by fluorescence spectrophotometry. LOX protein expression was detected by immunohistochemistry and Western blot. The mRNA expression of LOX in the pulmonary artery was detected by real-time PCR. RESULTS: The levels of mean pulmonary artery pressure (mPAP), RV/(LV+S) and WA/TA in hypoxia group were significantly higher than those in normoxia group (P<0.01). Moreover, the levels of mPAP and RV/(LV+S) in hypoxia+hypercapnia group were significantly lower than those in hypoxia group (P<0.01). However, no significant difference of mPAP and RV/(LV+S) between hypercapnia group and normoxia group was observed. In hypoxia group, the collagen cross-links in the lung tissue was significantly higher than that in normoxia group and hypercapnia group (P<0.01). Importantly, collagen cross-links in the lung tissue of hypoxia+hypercapnia group was significantly lower than that in hypoxia group (P<0.01). There was no significant difference in collagen cross-links between hypercapnia group and normoxia group. The expression of LOX at mRNA and protein levels and its activity in the pulmonary arteries of hypoxia group were significantly increased as compared with normoxia group (P<0.01). Furthermore, the expression of LOX at mRNA and protein levels and its activity in the pulmonary arteries in hypoxia+hypercapnia group were lower than those in hypoxia group (P<0.01). CONCLUSION: Hypoxia not only up-regulates LOX but also promotes collagen cross-linking in the rat lung, which contributes to the development of pulmonary hypertension. Hypercapnia inhibits hypoxia-induced LOX expression and collagen cross-linking, therefore impairing the progress in hypoxia-induced pulmonary hypertension.     

虫茶联合缬沙坦治疗原发性高血压临床观察

目的 观察虫茶联合缬沙坦治疗原发性高血压的疗效。方法 将符合诊断标准的144例原发性高血压患者随机分为两组,治疗组72例给予虫茶及缬沙坦治疗,对照组72例单纯应用缬沙坦治疗。两组连续治疗4周后比较其临床疗效。结果 治疗组显效率为40.3%,总有效率为87.5%,对照组分别为25.0%和76.4%,两组疗效比较差异有统计学意义（P<0.05）。两组治疗后收缩压及舒张压比较差异有统计学意义（P<0.05）,治疗组优于对照组。结论 虫茶联合缬沙坦治疗原发性高血压疗效确切。     

降糖降压汤对2型糖尿病合并高血压患者脂肪因子及细胞因子的影响

目的 探讨降糖降压汤对2型糖尿病合并高血压患者脂肪因子与细胞因子的影响。方法 将糖尿病合并高血压患者100例,按随机数字表法分为观察组和对照组各50例。对照组患者行常规西药降糖降压治疗,观察组患者在对照组治疗基础上,加用降糖降压汤治疗。治疗4周后,观察两组患者治疗前后血糖、血压、血脂及血浆他扎罗汀诱导基因 2（Chemerin）、血清同型半胱氨酸（Hcy）、脂联素（APN）、脑钠肽（BNP）的变化。结果 观察组总有效率为94%,对照组总有效率为76%,观察组明显高于对照组（P<0.05）;治疗后两组血糖、血压、血清三酰甘油（TG）、低密度脂蛋白胆固醇（LDL-C）、Chemerin、Hcy、BNP较治疗前均明显下降（P<0.05）,且观察组比对照组下降更明显（P<0.05）,高密度脂蛋白胆固醇（HDL-C）、APN较治疗前均有所上升（P<0.05）,且观察组比对照组上升更明显（P<0.05）。结论 降糖降压汤对2型糖尿病合并高血压患者的脂肪因子及细胞因子有较好的调节功效及临床疗效,值得临床推广。     

Evaluation of the white-coat effect in cats

The diagnosis and management of systemic hypertension in cats requires a reliable method for measurement of systemic arterial blood pressure (BP) in clinical patients. Unfortunately, the setting of a clinical practice and the act of measuring BP might raise BP and heart rate (HR), an effect referred to as the white-coat effect in human patients. The purpose of the present study was to determine if a white-coat effect was experienced by cats. Radiotelemetric implants were used to measure BP and HR in 13 conscious cats in a research colony while undisturbed in their cages and while subjected to simulated visits to a veterinarian's office. The white-coat effect was taken to be the difference between the overall 24-hour average value for parameters of BP and HR and the corresponding value during the simulated office visit. A white-coat effect was observed in cats. In healthy cats, the systolic BP measured during the examination period of the simulated office visit exceeded the 24-hour average systolic BP by 17.6+/-1.5 mm Hg. However, marked heterogeneity occurred in the pattern and magnitude of the increase in systolic BP above the 24-hour baseline and the increase varied between 75.3 and -27.2 mm Hg for the healthy cats. Variation in response to the simulated office visit was observed among cats and among visits by the same cat. During an office visit, the magnitude of the white-coat effect tended to decrease, but not disappear, over time. The magnitude of the white-coat effect varied when cats were subjected to 5 repeat office visits, but did not diminish in the group as a whole. The mean increase in systolic BP during the examination (22.3+/-0.9 mm Hg) was greater (P < .05) in cats with renal insufficiency. Although the heterogeneity of response expected from companion animals might be greater than that observed in these colony cats, these results indicate that veterinarians should carefully consider the white-coat effect in evaluation of BP in cats. A quiet, undisturbed environment and adequate time for acclimation should be included in the standard protocol for measurements of BP. Because of day-to-day variation in the white-coat effect in individual cats, multiple serial measurements following a standard protocol should provide the best estimate of BP in cats.     

Intraocular pressure development after cataract surgery: a prospective study in 50 dogs (1998-2000)

Objective To study the course of intraocular pressure (IOP) after cataract surgery in 50 dogs. Design Prospective study. Animals Fifty dogs without preoperative ocular hypertension were selected for cataract surgery. Methods All dogs underwent cataract surgery: 25 by manual extracapsular extraction and 25 by phacoemulsification. For each dog, intraocular pressure was measured before surgery, and 1, 3, 5, 18 h, 1 week and 1 month post surgery. Results No significant difference of mean intraocular pressure between the two surgical methods was observed for each time measurement. Nine dogs had postoperative hypertension (IOP > 25 mmHg) during the first 5 hours post surgery. Incidence of postoperative hypertension was not significantly different with manual extracapsular extraction (16%) vs. phacoemulsification (20%). A decrease of mean IOP was observed 1 h after surgery (8.49 mmHg vs. 10.91 mmHg), then an increase 3 and 5 h post surgery (12.3 and 13.32 mmHg, respectively). At 18 h, 1 week and 1 month post surgery, mean IOP decreased. Mean IOP was 10.38, 10.38 and 8.84 mmHg, respectively. Conclusion In this study incidence of POH is not high. However, a follow‐up of IOP in the first hours after cataract surgery is required to avoid complications of the retina and optic nerve and to administer hypotensive treatment if necessary.